{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T06:04:31Z","timestamp":1781071471784,"version":"3.54.1"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["FE 1929\/1\u20131"],"award-info":[{"award-number":["FE 1929\/1\u20131"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["FE 1929\/2\u20132"],"award-info":[{"award-number":["FE 1929\/2\u20132"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["BI 488\/5\u20132"],"award-info":[{"award-number":["BI 488\/5\u20132"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["WA 2597\/3\u20132"],"award-info":[{"award-number":["WA 2597\/3\u20132"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["INST 192\/543-1 FUGG"],"award-info":[{"award-number":["INST 192\/543-1 FUGG"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Gain-of-function (GOF) mutations in the cardiac pacemaker channel HCN4 have been associated with inappropriate sinus tachycardia in human patients. Chronic tachycardia is generally associated with adverse cardiac remodeling and cardiomyopathy, but whether enhanced HCN4 activity can induce or modulate such remodeling remains unknown. We aimed to investigate the influence of an HCN4 gain-of-function mutation on cardiac function and structure under baseline and pressure overload conditions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and Results<\/jats:title>\n                    <jats:p>\n                      We generated HCN4(Y527F) knock-in mice (HCN4F) carrying a GOF mutation in the C-linker of HCN4 channels, which shifts their activation curves to more positive potentials. Electrophysiological recordings confirmed increased channel availability at physiological membrane potentials. Telemetric ECGs and\n                      <jats:italic>in vivo<\/jats:italic>\n                      electrophysiological studies revealed an elevated mean and intrinsic heart rate, faster sinus node and atrioventricular conduction in HCN4F mice, but no spontaneous arrhythmias. In HCN4F mice, the heart rate histogram was truncated at lower heart rates, indicating fewer low-rate intervals and more frequent periods of elevated heart rate, while maximal heart rates remained comparable between the two phenotypes. Histological analysis did not reveal structural changes consistent with tachycardia-induced cardiomyopathy. Cardiac morphology, fibrosis, and contractility were indistinguishable between genotypes up to 12 months of age. Following transverse aortic constriction, both WT and HCN4F mice developed left ventricular hypertrophy, but HCN4F hearts exhibited less chamber dilatation, smaller left ventricular lumen, and preserved systolic function compared to WT. Gene expression and RNA-sequencing analyses revealed activation of a typical hypertrophic gene program in both genotypes, but distinct remodeling signatures.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>The HCN4(Y527F) gain-of-function mutation increases intrinsic heart rate without inducing structural or functional deterioration. Under pressure overload, it even confers considerable protection against maladaptive dilatation and contractile dysfunction. These findings challenge the concept that persistent inappropriately elevated heart rate is necessarily detrimental and suggest that enhanced HCN4 activity may facilitate adaptive cardiac responses to stress.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2026.1840832","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T05:39:56Z","timestamp":1781069996000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["HCN4 gain-of-function mutation increases intrinsic heart rate and limits maladaptive remodeling under pressure overload"],"prefix":"10.3389","volume":"17","author":[{"given":"Konstantin","family":"Hennis","sequence":"first","affiliation":[{"name":"Department of Pharmacy \u2013 Center for Drug Research, Pharmacology for Natural Sciences, Ludwig-Maximilians Universit\u00e4t M\u00fcnchen","place":["Munich, Germany"]},{"name":"Institute of Cardiovascular Physiology and Pathophysiology, Biomedical Center Munich, Ludwig-Maximilians Universit\u00e4t M\u00fcnchen","place":["Planegg-Martinsried, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Rilling","sequence":"additional","affiliation":[{"name":"Department of Pharmacy \u2013 Center for Drug Research, Pharmacology for Natural Sciences, Ludwig-Maximilians Universit\u00e4t M\u00fcnchen","place":["Munich, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linh","family":"Pham","sequence":"additional","affiliation":[{"name":"Department of Pharmacy \u2013 Center for Drug Research, Pharmacology for Natural Sciences, Ludwig-Maximilians Universit\u00e4t M\u00fcnchen","place":["Munich, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9","family":"R\u00f6tzer","sequence":"additional","affiliation":[{"name":"Department of Pharmacy \u2013 Center for Drug Research, Pharmacology for Natural Sciences, Ludwig-Maximilians Universit\u00e4t M\u00fcnchen","place":["Munich, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Piantoni","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Physiology and Pathophysiology, Biomedical Center Munich, Ludwig-Maximilians Universit\u00e4t M\u00fcnchen","place":["Planegg-Martinsried, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yakun","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy \u2013 Center for Drug Research, Pharmacology for Natural Sciences, Ludwig-Maximilians Universit\u00e4t M\u00fcnchen","place":["Munich, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Auerbach","sequence":"additional","affiliation":[{"name":"Department of Pharmacy \u2013 Center for Drug Research, Pharmacology for Natural Sciences, Ludwig-Maximilians Universit\u00e4t M\u00fcnchen","place":["Munich, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Groher","sequence":"additional","affiliation":[{"name":"Department of Pharmacy \u2013 Center for Drug Research, Pharmacology for Natural Sciences, Ludwig-Maximilians Universit\u00e4t M\u00fcnchen","place":["Munich, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Kruck","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Physiology and Pathophysiology, Biomedical Center Munich, Ludwig-Maximilians Universit\u00e4t M\u00fcnchen","place":["Planegg-Martinsried, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Koplitz-Wei\u00dfgerber","sequence":"additional","affiliation":[{"name":"Department of Pharmacy \u2013 Center for Drug Research, Pharmacology for Natural Sciences, Ludwig-Maximilians Universit\u00e4t M\u00fcnchen","place":["Munich, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Gruner","sequence":"additional","affiliation":[{"name":"Department of Pharmacy \u2013 Center for Drug Research, Pharmacology for Natural Sciences, Ludwig-Maximilians Universit\u00e4t M\u00fcnchen","place":["Munich, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Scharr","sequence":"additional","affiliation":[{"name":"Department of Pharmacy \u2013 Center for Drug Research, Pharmacology for Natural Sciences, Ludwig-Maximilians Universit\u00e4t M\u00fcnchen","place":["Munich, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verena","family":"Mehlfeld","sequence":"additional","affiliation":[{"name":"Department of Pharmacy \u2013 Center for Drug Research, Pharmacology for Natural Sciences, Ludwig-Maximilians Universit\u00e4t M\u00fcnchen","place":["Munich, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Biel","sequence":"additional","affiliation":[{"name":"Department of Pharmacy \u2013 Center for Drug Research, Pharmacology for Natural Sciences, Ludwig-Maximilians Universit\u00e4t M\u00fcnchen","place":["Munich, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Wahl-Schott","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Physiology and Pathophysiology, Biomedical Center Munich, Ludwig-Maximilians Universit\u00e4t M\u00fcnchen","place":["Planegg-Martinsried, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Fenske","sequence":"additional","affiliation":[{"name":"Department of Pharmacy \u2013 Center for Drug Research, Pharmacology for Natural Sciences, Ludwig-Maximilians Universit\u00e4t M\u00fcnchen","place":["Munich, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,10]]},"reference":[{"key":"B2","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1093\/eurheartj\/ehv582","article-title":"A gain-of-function mutation in the cardiac pacemaker HCN4 channel increasing cAMP sensitivity is associated with familial inappropriate sinus tachycardia","volume":"38","author":"Baruscotti","year":"2017","journal-title":"Eur. Heart J."},{"key":"B3","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1152\/physrev.00029.2008","article-title":"Hyperpolarization-activated cation channels: from genes to function","volume":"89","author":"Biel","year":"2009","journal-title":"Physiol. Rev."},{"key":"B4","doi-asserted-by":"publisher","first-page":"euaf085.005","DOI":"10.1093\/europace\/euaf085.005","article-title":"A novel gain-of-function HCN4 variant responsible for familial inappropriate sinus tachycardia","volume":"27","author":"Bober","year":"2025","journal-title":"Europace"},{"key":"B5","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1113\/jphysiol.1980.sp013474","article-title":"Voltage-clamp investigations of membrane currents underlying pace-maker activity in rabbit sino-atrial node","volume":"308","author":"Brown","year":"1980","journal-title":"J. Physiol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e2305135120","DOI":"10.1073\/pnas.2305135120","article-title":"A gain-of-function HCN4 mutant in the HCN domain is responsible for inappropriate sinus tachycardia in a Spanish family","volume":"120","author":"Camara-Checa","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1093\/eurheartj\/ehs391","article-title":"Altered HCN4 channel C-linker interaction is associated with familial tachycardia-bradycardia syndrome and atrial fibrillation","volume":"34","author":"Duhme","year":"2013","journal-title":"Eur. Heart J."},{"key":"B11","doi-asserted-by":"publisher","first-page":"82","DOI":"10.15420\/aer.2013.2.2.82","article-title":"What about tachycardia-induced cardiomyopathy?","volume":"2","author":"Ellis","year":"2013","journal-title":"Arrhythm. Electrophysiol. Rev."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1161\/circresaha.111.246173","article-title":"HCN3 contributes to the ventricular action potential waveform in the murine heart","volume":"109","author":"Fenske","year":"2011","journal-title":"Circ. Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.1161\/CIRCULATIONAHA.113.003712","article-title":"Sick sinus syndrome in HCN1-deficient mice","volume":"128","author":"Fenske","year":"2013","journal-title":"Circulation"},{"key":"B15","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/nprot.2015.139","article-title":"Comprehensive multilevel in vivo and in vitro analysis of heart rate fluctuations in mice by ECG telemetry and electrophysiology","volume":"11","author":"Fenske","year":"2016","journal-title":"Nat. Protoc."},{"key":"B16","doi-asserted-by":"publisher","first-page":"5555","DOI":"10.1038\/s41467-020-19304-9","article-title":"cAMP-dependent regulation of HCN4 controls the tonic entrainment process in sinoatrial node pacemaker cells","volume":"11","author":"Fenske","year":"2020","journal-title":"Nat. Commun."},{"key":"B19","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s00424-022-02698-4","article-title":"Paradigm shift: new concepts for HCN4 function in cardiac pacemaking","volume":"474","author":"Hennis","year":"","journal-title":"Pflugers Arch."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1038\/s41596-021-00678-z","article-title":"In vivo and ex vivo electrophysiological study of the mouse heart to characterize the cardiac conduction system, including atrial and ventricular vulnerability","volume":"17","author":"Hennis","year":"","journal-title":"Nat. Protoc."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1161\/CIRCRESAHA.123.323250","article-title":"Pacemaker channels and the chronotropic response in health and disease","volume":"134","author":"Hennis","year":"2024","journal-title":"Circ. Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1001\/jamacardio.2022.5320","article-title":"Effect of personalized accelerated pacing on quality of life, physical activity, and atrial fibrillation in patients with preclinical and overt heart failure with preserved ejection fraction: the myPACE randomized clinical trial","volume":"8","author":"Infeld","year":"2023","journal-title":"JAMA Cardiol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"H1031","DOI":"10.1152\/ajpheart.00301.2016","article-title":"Heart rate-induced modifications of concentric left ventricular hypertrophy: exploration of a novel therapeutic concept","volume":"311","author":"Klein","year":"2016","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.hrthm.2014.03.002","article-title":"A novel trafficking-defective HCN4 mutation is associated with early-onset atrial fibrillation","volume":"11","author":"Macri","year":"2014","journal-title":"Heart Rhythm."},{"key":"B31","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.pharmthera.2013.10.007","article-title":"Small and large animal models in cardiac contraction research: advantages and disadvantages","volume":"141","author":"Milani-Nejad","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"B32","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.jacc.2014.05.045","article-title":"HCN4 mutations in multiple families with bradycardia and left ventricular noncompaction cardiomyopathy","volume":"64","author":"Milano","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.hroo.2024.03.010","article-title":"Rate-adaptive pacing in heart failure with preserved ejection fraction: too much of a good thing?","author":"Oraii","year":"2024","journal-title":"Heart Rhythm."},{"key":"B36","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1007\/s00246-011-9964-1","article-title":"A pediatric case of cardiomyopathy induced by inappropriate sinus tachycardia: efficacy of ivabradine","volume":"32","author":"Romeo","year":"2011","journal-title":"Pediatr. Cardiol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"212","DOI":"10.14744\/AnatolJCardiol.2016.6813","article-title":"Inappropriate sinus tachycardia-induced cardiomyopathy during pregnancy and successful treatment with ivabradine","volume":"16","author":"Sag","year":"2016","journal-title":"Anatol. J. Cardiol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"key":"B39","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/s0735-1097(96)00592-x","article-title":"Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies","volume":"29","author":"Shinbane","year":"1997","journal-title":"J. Am. Coll. Cardiol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"27194","DOI":"10.1074\/jbc.M311953200","article-title":"Functional characterization of a trafficking-defective HCN4 mutation, D553N, associated with cardiac arrhythmia","volume":"279","author":"Ueda","year":"2004","journal-title":"J. Biol. Chem."},{"key":"B44","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/jhg.2008.16","article-title":"Role of HCN4 channel in preventing ventricular arrhythmia","volume":"54","author":"Ueda","year":"2009","journal-title":"J. Hum. Genet."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/j.amjcard.2019.07.008","article-title":"Effects of a higher heart rate on quality of life and functional capacity in patients with left ventricular diastolic dysfunction","volume":"124","author":"Wahlberg","year":"2019","journal-title":"Am. J. Cardiol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1111\/j.1540-8159.2009.02414.x","article-title":"A case of cardiomyopathy induced by inappropriate sinus tachycardia and cured by ivabradine","volume":"32","author":"Winum","year":"2009","journal-title":"Pacing Clin. Electrophysiol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1007\/s00380-018-1116-6","article-title":"A mutant HCN4 channel in a family with bradycardia, left bundle branch block, and left ventricular noncompaction","volume":"33","author":"Yokoyama","year":"2018","journal-title":"Heart Vessels"},{"key":"B51","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1253\/circj.cj-13-0996","article-title":"A novel HCN4 mutation, G1097W, is associated with atrioventricular block","volume":"78","author":"Zhou","year":"2014","journal-title":"Circ. J."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1840832\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T05:39:57Z","timestamp":1781069997000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1840832\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":30,"alternative-id":["10.3389\/fphar.2026.1840832"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1840832","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,10]]},"article-number":"1840832"}}